TrialAmerican journal of respiratory and critical care medicine2023

High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.

Raffaele Di Fenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.